Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07300670

The Effect of Losartan on Cephalexin

Status
Recruiting
Phase
Phase 1
Study type
Interventional
Enrollment
12 (estimated)
Sponsor
Aleksi Tornio · Other Government
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

The goal of this clinical trial is to investigate the effects of the blood pressure-lowering drug losartan on the blood levels and urinary excretion of the antibiotic cephalexin during simultaneous and staggered ingestion in healthy volunteers. The main questions it aims to answer are: 1. Does losartan affect cephalexin levels and excretion when ingested at the same time? 2. Does a three-hour interval between ingestion of losartan and cephalexin eliminate a possible effect? Researchers will compare the effects of losartan ingested at the same time, losartan ingested three hours prior, and no losartan ingested on oral cephalexin in each participant to see whether an interaction exists and could be avoided. Participants will visit the research laboratory on three days during which they will ingest single doses of losartan at the same time with, three hours prior to, and not at all prior to ingesting single doses of cephalexin.

Conditions

Interventions

TypeNameDescription
DRUGlosartan100 mg tablet orally, single dose
DRUGcephalexin500 mg tablet orally, single dose

Timeline

Start date
2026-03-04
Primary completion
2026-05-08
Completion
2026-05-08
First posted
2025-12-24
Last updated
2026-03-25

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT07300670. Inclusion in this directory is not an endorsement.